Bloom, Barry and Michael Page, Feb. 13, 1987
Scope and Contents
Institution: Pfizer. Topics: entering into the field of recombinant DNA research and molecular genetics; recombinant techniques used in oncology; oncogenes; research efforts; using small biotechnology companies as part of research strategy; tPA processing technique for generating protein treatments; strategic drug production directions; developing a competitive edge; in-house scientific culture; benefits of being a multi-national organization; understanding patient/physician and basic science needs; different focuses/importance of British pharmacology versus work being done in the U.S.
Dates
- Creation: Feb. 13, 1987
Scope and Contents
Institution: Pfizer. Topics: entering into the field of recombinant DNA research and molecular genetics; recombinant techniques used in oncology; oncogenes; research efforts; using small biotechnology companies as part of research strategy; tPA processing technique for generating protein treatments; strategic drug production directions; developing a competitive edge; in-house scientific culture; benefits of being a multi-national organization; understanding patient/physician and basic science needs; different focuses/importance of British pharmacology versus work being done in the U.S.
Collecting Area Details
Part of the Archives and Modern Manuscripts Collections Collecting Area
8600 Rockville Pike
Bldg 38/1E-21, MSC 3819
Bethesda MD 20894 US
1-888-FINDNLM (1-888-346-3656)
nlm-support@nlm.nih.gov